Structural characterization of S100A15 reveals a novel zinc coordination site among S100 proteins and altered surface chemistry with functional implications for receptor binding

BMC Structural Biology

Volumn 12, Issue , 2012, Pages

  Murray, Jill I ^a   Tonkin, Michelle L ^a   Whiting, Amanda L ^a   Peng, Fangni ^a   Farnell, Benjamin ^a   Cullen, Jay T ^a   Hof, Fraser ^a   Boulanger, Martin J ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

EF hand; S100A15; S100A7; X ray crystallography; Zinc binding

Indexed keywords

ASPARTIC ACID; CHLORIDE ION; DIMER; PROTEIN S 100; PSORIASIN; S100A15 PROTEIN; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CLUSTER ANALYSIS; CRYSTAL STRUCTURE; METAL BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; SURFACE PROPERTY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SURFACE PROPERTIES; ZINC;

EID: 84863087152     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-12-16     Document Type: Article

References (41)

1. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Donato R, Curr Mol Med 2007 7 8 711 724 10.2174/156652407783220688 18331229
2. Calcium-dependent and -independent interactions of the S100 protein family. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS, Biochem J 2006 396 2 201 214 10.1042/BJ20060195 16683912 (Pubitemid 43837235)
3. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Donato R, Biochim Biophys Acta 1999 1450 3 191 231 10.1016/S0167-4889(99)00058-0 10395934 (Pubitemid 29295473)
4. S100 proteins in the epidermis. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K, J Investig Dermatol 2004 123 1 23 33 10.1111/j.0022-202X.2004. 22719.x 15191538 (Pubitemid 38833459)
5. S100 proteins and their influence on pro-survival pathways in cancer. Emberley ED, Murphy LC, Watson PH, Biochem Cell Biol 2004 82 4 508 515 10.1139/o04-052 15284904 (Pubitemid 39286966)
6. Pathologies involving the S100 proteins and RAGE. Heizmann CW, Ackermann GE, Galichet A, Subcell Biochem 2007 45 93 138 10.1007/978-1-4020-6191-2-5 18193636
7. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Donato R, Int J Biochem Cell Biol 2001 33 7 637 668 10.1016/S1357-2725(01)00046-2 11390274 (Pubitemid 32520962)
8. Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding. West NR, Farnell B, Murray JI, Hof F, Watson PH, Boulanger MJ, Protein Sci 2009 18 12 2615 2623 10.1002/pro.274 19844956
9. Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways. Leon R, Murray JI, Cragg G, Farnell B, West NR, Pace TC, Watson PH, Bohne C, Boulanger MJ, Hof F, Biochemistry 2009 48 44 10591 10600 10.1021/bi901330g 19810752
10. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et al. J Investig Dermatol 1991 97 4 701 712 10.1111/1523-1747.ep12484041 1940442
11. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC, Watson PH, Cancer Res 1996 56 20 4606 4609 8840971 (Pubitemid 26338057)
12. A putative role for psoriasin in breast tumor progression. Krop I, Marz A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, et al. Cancer Res 2005 65 24 11326 11334 10.1158/0008-5472.CAN-05- 1523 16357139 (Pubitemid 41821689)
13. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Enerback C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, et al. Cancer Res 2002 62 1 43 47 11782356 (Pubitemid 34073983)
14. Psoriasin (S100A7) expression and invasive breast cancer. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy LC, Watson PH, Am J Pathol 1999 155 6 2057 2066 10.1016/S0002-9440(10)65524-1 10595935
15. S100A7 and the progression of breast cancer. Emberley ED, Murphy LC, Watson PH, Breast Cancer Res 2004 6 4 153 159 10.1186/bcr816 15217486 (Pubitemid 39136481)
16. Psoriasin interacts with Jab1 and influences breast cancer progression. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH, Cancer Res 2003 63 8 1954 1961 12702588 (Pubitemid 36460863)
17. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, Myers JN, Gibson SB, Murphy LC, Watson PH, Cancer Res 2005 65 13 5696 5702 10.1158/0008-5472.CAN-04-3927 15994944 (Pubitemid 40911172)
18. Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. Wolf R, Mirmohammadsadegh A, Walz M, Lysa B, Tartler U, Remus R, Hengge U, Michel G, Ruzicka T, FASEB J 2003 17 13 1969 1971 12923069
19. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Wolf R, Ruzicka T, Yuspa SH, Amino Acids 2011 41 4 789 796 10.1007/s00726-010-0666-4 20596736
20. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, et al. J Immunol 2008 181 2 1499 1506 18606705
21. Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P, Gunsior M, Vonderhaar BK, Olson M, Watson PH, Yuspa SH, Cancer Lett 2009 277 1 101 107 10.1016/j.canlet.2008.11.032 19136201
22. Psoriasin: a novel chemotactic protein. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE, Thestrup-Pedersen K, J Investig Dermatol 1996 107 1 5 10 10.1111/1523-1747. ep12294284 8752830
23. The role of zinc in the S100 proteins: insights from the X-ray structures. Moroz OV, Wilson KS, Bronstein IB, Amino Acids 2011 41 4 761 772 10.1007/s00726-010-0540-4 20306096
24. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM, Nat Immunol 2005 6 1 57 64 10.1038/ni1142 15568027 (Pubitemid 40136696)
25. Coordination dynamics of zinc in proteins. Maret W, Li Y, Chem Rev 2009 109 10 4682 4707 10.1021/cr800556u 19728700
26. The finer things in X-ray diffraction data collection. Pflugrath J, Acta Crystallog sect D 1999 55 1718 1725 10.1107/S090744499900935X (Pubitemid 29504426)
27. Overview of the CCP4 suite and current developments. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, et al. Acta Crystallogr D Biol Crystallogr 2011 67 4 235 242 10.1107/S0907444910045749 21460441
28. Refinement of macromolecular structures by the maximum-likelihood method. Murshudov GN, Vagin AA, Dodson EJ, Acta Crystallog sect D 1997 53 240 255 10.1107/S0907444996012255 (Pubitemid 27235885)
29. Coot: model-building tools for molecular graphics. Emsley P, Cowtan K, Acta Crystallog sect D 2004 60 2126 2132 10.1107/S0907444904019158 (Pubitemid 41742764)
30. Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+bound human psoriasin (S100A7) in the Zn2+loaded and Zn2+free states. Brodersen DE, Nyborg J, Kjeldgaard M, Biochemistry 1999 38 6 1695 1704 10.1021/bi982483d 10026247 (Pubitemid 29085316)
31. Determination of Metal-Organic Complexation in Natural-Waters by Swasv with Pseudopolarograms. Lewis BL, Luther GW, Lane H, Church TM, Electroanalysis 1995 7 2 166 177 10.1002/elan.1140070213
32. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. Moroz OV, Burkitt W, Wittkowski H, He W, Ianoul A, Novitskaya V, Xie J, Polyakova O, Lednev IK, Shekhtman A, et al. BMC Biochem 2009 10 11 10.1186/1471-2091-10-11 19386136
33. Expression and divalent cation binding properties of the novel chemotactic inflammatory protein psoriasin. Vorum H, Madsen P, Rasmussen HH, Etzerodt M, Svendsen I, Celis JE, Honore B, Electrophoresis 1996 17 11 1787 1796 10.1002/elps.1150171118 8982613 (Pubitemid 26402938)
34. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis. Wilder PT, Baldisseri DM, Udan R, Vallely KM, Weber DJ, Biochemistry 2003 42 46 13410 13421 10.1021/bi035334q 14621986 (Pubitemid 37444890)
35. Structural basis for ligand recognition and activation of RAGE. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ, Fritz G, Structure 2010 18 10 1342 1352 10.1016/j.str.2010.05.017 20947022
36. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. Webb M, Emberley ED, Lizardo M, Alowami S, Qing G, Alfia'ar A, Snell-Curtis LJ, Niu Y, Civetta A, Myal Y, et al. BMC Cancer 2005 5 17 10.1186/1471-2407-5-17 15717926 (Pubitemid 41461110)
37. Structural and functional insights into RAGE activation by multimeric S100B. Ostendorp T, Leclerc E, Galichet A, Koch M, Demling N, Weigle B, Heizmann CW, Kroneck PM, Fritz G, EMBO J 2007 26 16 3868 3878 10.1038/sj.emboj.7601805 17660747 (Pubitemid 47295872)
38. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. Xie J, Burz DS, He W, Bronstein IB, Lednev I, Shekhtman A, J Biol Chem 2007 282 6 4218 4231 17158877 (Pubitemid 47084493)
39. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A, J Biol Chem 2007 282 43 31317 31331 10.1074/jbc.M703951200 17726019 (Pubitemid 350044892)
40. The 1.5 A crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. Park H, Adsit FG, Boyington JC, J Biol Chem 2010 285 52 40762 40770 10.1074/jbc.M110.169276 20943659
41. Intracellular zinc homeostasis and zinc signaling. Murakami M, Hirano T, Cancer Sci 2008 99 8 1515 1522 10.1111/j.1349-7006.2008.00854.x 18754861